Business Description
Rhinomed Ltd
ISIN : AU000000RNO1
Description
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | -2.08 | |||||
| Debt-to-Equity | -0.93 | |||||
| Debt-to-EBITDA | -0.62 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -50.24 | |||||
| Beneish M-Score | -8.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.7 | |||||
| 3-Year EBITDA Growth Rate | 8.9 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year FCF Growth Rate | 10.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.08 | |||||
| 9-Day RSI | 68.21 | |||||
| 14-Day RSI | 64.8 | |||||
| 6-1 Month Momentum % | -54.29 | |||||
| 12-1 Month Momentum % | -64.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.27 | |||||
| Quick Ratio | 0.2 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 208.75 | |||||
| Days Sales Outstanding | 65.24 | |||||
| Days Payable | 444 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 | |||||
| Shareholder Yield % | -43.47 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.82 | |||||
| Operating Margin % | -121.69 | |||||
| Net Margin % | -145.97 | |||||
| FCF Margin % | -97.32 | |||||
| ROA % | -157.09 | |||||
| ROIC % | -141.84 | |||||
| ROC (Joel Greenblatt) % | -1421.52 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.54 | |||||
| EV-to-EBIT | -1.63 | |||||
| EV-to-EBITDA | -1.77 | |||||
| EV-to-Revenue | 2.31 | |||||
| EV-to-FCF | -2.37 | |||||
| Earnings Yield (Greenblatt) % | -61.35 | |||||
| FCF Yield % | -63.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rhinomed Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 7.473 | ||
| EPS (TTM) (A$) | -0.038 | ||
| Beta | 0 | ||
| Volatility % | 66.17 | ||
| 14-Day RSI | 64.8 | ||
| 14-Day ATR (A$) | 0.002246 | ||
| 20-Day SMA (A$) | 0.0303 | ||
| 12-1 Month Momentum % | -64.44 | ||
| 52-Week Range (A$) | 0.019 - 0.1 | ||
| Shares Outstanding (Mil) | 286.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rhinomed Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rhinomed Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rhinomed Ltd Frequently Asked Questions
What is Rhinomed Ltd(ASX:RNO)'s stock price today?
The current price of ASX:RNO is A$0.04. The 52 week high of ASX:RNO is A$0.10 and 52 week low is A$0.02.
When is next earnings date of Rhinomed Ltd(ASX:RNO)?
The next earnings date of Rhinomed Ltd(ASX:RNO) is .
Does Rhinomed Ltd(ASX:RNO) pay dividends? If so, how much?
Rhinomed Ltd(ASX:RNO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers